Generally, the experimental results evidenced that CAPE-pNO2 likely via inhibiting the EGFR/STAT3/Akt/E-cadherin signaling pathway to against growth and metastasis of breast cancer in vivo and in vitro. This evidence concerns the gene CDH1 and breast cancer.